Galecto Raises $64 Million to Accelerate Development of Clinical Pipeline
25 September 2020

Galecto Raises $64 Million to Accelerate Development of Clinical Pipeline

Galecto., a privately-held biotechnology company focused on the development of novel treatments for fibrosis and cancer, announced today the successful completion of a $64...

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse